.avif)
Illumina Email Format
Biotechnology Research
・
5,001-10,000 employees
・
San Diego, CA, USA
Illumina is a global biotechnology company that develops and manufactures innovative sequencing and array-based solutions for DNA, RNA, and protein analysis in research and clinical applications.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@illumina.com
Company Overview
Industry
Biotechnology Research
Founded
1998
Headquarters
San Diego, CA, USA
Revenue
$2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
Jacob Thaysen (Chief Executive Officer and Interim Chief Commercial Officer), Ankur Dhingra (Chief Financial Officer), Kevin Pegels (Chief of Global Operations)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Illumina?
Illumina uses the firstinitiallast format on illumina.com, so Jane Smith would be jsmith@illumina.com.
What sequencing platforms does Illumina offer for large-scale genomic research?
Illumina offers a range of next-generation sequencing systems including the NovaSeq X Series for high-throughput work and the NextSeq 1000 and 2000 for mid-scale research, alongside benchtop options like the MiSeq i100 Series and iSeq 100.
How many countries does Illumina serve with its genomics technologies?
Illumina serves customers in 165 countries, providing sequencing and array-based solutions for life science research, oncology, reproductive health, and molecular diagnostics. You can use Clay to find and verify Illumina contacts in specific regions for targeted outreach.
Who leads Illumina as its chief executive today?
Jacob Thaysen serves as Chief Executive Officer and Interim Chief Commercial Officer of Illumina, with Ankur Dhingra as Chief Financial Officer and Kevin Pegels as Chief of Global Operations.
What is Illumina's TruSight Oncology product family used for?
Illumina's TruSight Oncology product family provides in vitro diagnostic and clinical research solutions for solid tumor genomic analysis, helping labs identify relevant genomic changes in cancer through next-generation sequencing workflows.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating